No profile data available.
Codexis, Inc. (CDXS) is a non-energy raw materials company in the additional chemical compound production industry, based in Redwood City, United States, with about 146 full-time employees.
It reported revenue of $70.39 million for fiscal year 2025, up 18.6% from fiscal year 2024, and net income of -$43.97 million. United States, Canada, Latin America was its largest region in fiscal year 2025, with 62% of revenue. Its market capitalization was $154.40 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.
Codexis reported $70.39 million in revenue for fiscal year 2025, up 18.6% from $59.35 million in fiscal year 2024.
United States, Canada, Latin America: 62% of revenue by region in fiscal year 2025, followed by China (13%).
$154.40 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional chemical compound production) include Kornit Digital Ltd. (KRNT), Valhi, Inc. (VHI), Arq, Inc. (ARQ), Flexible Solutions International, Inc. (FSI).